Alison M. Grimes, Head, Audiology Clinic, Assistant Clinical Professor, Head and Neck Surgery, University of California, Los Angeles, discusses newborn hearing screening, which is now mandatory in all…
Alison M. Grimes, Head, Audiology Clinic, Assistant Clinical Professor, Head and Neck Surgery, University of California, Los Angeles, discusses newborn hearing screening, and the consequences of delayed diagnosis…
Alison M. Grimes, Head, Audiology Clinic, Assistant Clinical Professor, Head and Neck Surgery, University of California, Los Angeles, discusses new hearing aids, which use digital signaling to differentiate…
Michael Swiernik, MD, Director, Medical Informatics, University of California, Los Angeles, discusses electronic medical records (EMR) at UCLA, including data access for doctors, web portals, inpatient nursing electronic…
Marsha Guess, MD, Assistant Professor of Obstetrics, Gynecology and Reproductive Medicine at Yale University, discusses overactive bladder treatment with newer drugs such as trospium chloride, and reminds physicians…
Marsha Guess, MD, Assistant Professor of Obstetrics, Gynecology and Reproductive Medicine at Yale University, discusses altered sexual function in women and a Yale study that is looking at…
Christian Pettker, MD, Assistant Professor, Department of Obstetrics, Gynecology and Reproductive Science, Yale University, discusses multiple pregnancies, the risks associated with them and how they can be made…
Randolph Schiffer, MD, Medical Director, Lou Ruvo Center for Brain Health, Cleveland Clinic, discusses brain health and cognitive loss, its increasing importance across all disciplines of medicine and…
NEW YORK (Reuters Health) – Because cholinesterase inhibitors induce can bradycardia, particularly at higher doses, physicians are being urged to closely monitor patients treated with these medications, especially…
NEW YORK (Reuters Health) – New research indicates that tenofovir 300 mg-emtricitabine 200 mg (TDF-FTC) is comparable to abacavir 600 mg-lamivudine 300 mg (ABC-3TC) in anti-HIV efficacy but…
NEW YORK (Reuters Health) – Use of erythropoiesis-stimulating agents in US cancer patients undergoing chemotherapy has increased 10-fold since their introduction, yet there’s been no associated decline in…
NEW YORK (Reuters Health) – After breast-conserving surgery for invasive cancer, mammographic density is a risk factor for local recurrence, particularly in women who don’t undergo radiotherapy, investigators…
